Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
2.
Clin Appl Thromb Hemost ; 28: 10760296221117482, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35898172

RESUMO

CONCLUSION: Routine use of WBPA studies enables safe and effective risk-adapted thromboprophylaxis in MPN patients, irrespective of the underlying driver mutation and their risk predicted by the IPSET- thrombosis criteria.


Assuntos
Transtornos Mieloproliferativos , Neoplasias , Trombose , Tromboembolia Venosa , Anticoagulantes , Humanos , Transtornos Mieloproliferativos/complicações , Transtornos Mieloproliferativos/genética , Agregação Plaquetária , Medição de Risco , Trombose/genética , Trombose/prevenção & controle
3.
Pathology ; 53(2): 247-256, 2021 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-33032809

RESUMO

Heparin induced thrombocytopenia (HIT) is a rare but potentially fatal complication of heparin therapy. In some patients, HIT causes platelet activation and thrombosis (sometimes abbreviated HITT), which leads to adverse clinical sequalae ('pathological HIT'). The likelihood of HIT is initially assessed clinically, typically using a scoring system, of which the 4T score is that most utilised. Subsequent laboratory testing to confirm or exclude HIT facilitates exclusion or diagnosis and management. The current investigation comprises a multicentre (n=9) assessment of contemporary laboratory testing for HIT, as performed over the past 1-3 years in each site and comprising testing of over 1200 samples. The primary laboratory test used by study participants (n=8) comprised a chemiluminescence procedure (HIT-IgG(PF4-H)) performed on an AcuStar instrument. Additional immunological testing performed by study sites included lateral flow (STiC, Stago), enzyme linked immunosorbent assay (ELISA), Asserachrom (HPIA IgG), PaGIA (BioRad), plus functional assays, primarily serotonin release assay (SRA) or platelet aggregation methods. The chemiluminescence procedure yielded a highly sensitive screening method for identifying functional HIT, given high area under the curve (AUC, generally ≥0.9) in a receiver operator characteristic (ROC) analysis against SRA as gold standard. ELISA testing resulted in lower ROC AUC scores (<0.8) and higher levels of false positives. Although there is clear association with the likelihood of HIT, the 4T score had less utility than literature suggests, and was comparable to a previous study reported by some of the authors.


Assuntos
Testes Diagnósticos de Rotina/métodos , Heparina/efeitos adversos , Trombocitopenia/diagnóstico , Anticoagulantes/efeitos adversos , Anticoagulantes/uso terapêutico , Ensaio de Imunoadsorção Enzimática , Feminino , Heparina/uso terapêutico , Humanos , Laboratórios Hospitalares , Masculino , Agregação Plaquetária , Curva ROC , Trombocitopenia/etiologia , Trombose/induzido quimicamente
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA